Compounds > 5-(3-methyl-1-triazeno)imidazole-4-carboxamide
Page last updated: 2024-08-25

5-(3-methyl-1-triazeno)imidazole-4-carboxamide and Leukemia

5-(3-methyl-1-triazeno)imidazole-4-carboxamide has been researched along with Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonmassar, E; D'Atri, S; Gilberti, S; Graziani, G; Lacal, PM; Tentori, L1

Other Studies

1 other study(ies) available for 5-(3-methyl-1-triazeno)imidazole-4-carboxamide and Leukemia

ArticleYear
Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.
    Leukemia, 1995, Volume: 9, Issue:11

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Dacarbazine; Gene Expression; Humans; Leukemia; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; RNA, Messenger; Temozolomide; Tumor Cells, Cultured

1995